| Year |
Citation |
Score |
| 2023 |
Kalita M, Park JH, Kuo RC, Hayee S, Marsango S, Straniero V, Alam IS, Rivera-Rodriguez A, Pandrala M, Carlson ML, Reyes ST, Jackson IM, Suigo L, Luo A, Nagy SC, et al. PET Imaging of Innate Immune Activation Using C Radiotracers Targeting GPR84. Jacs Au. 3: 3297-3310. PMID 38155640 DOI: 10.1021/jacsau.3c00435 |
0.617 |
|
| 2023 |
Carlson ML, Jackson IM, Azevedo EC, Reyes ST, Alam IS, Kellow R, Castillo JB, Nagy SC, Sharma R, Brewer M, Cleland J, Shen B, James ML. Development and Initial Assessment of [F]OP-801: a Novel Hydroxyl Dendrimer PET Tracer for Preclinical Imaging of Innate Immune Activation in the Whole Body and Brain. Molecular Imaging and Biology. PMID 37735280 DOI: 10.1007/s11307-023-01850-5 |
0.592 |
|
| 2023 |
Jackson IM, Carlson ML, Beinat C, Malik N, Kalita M, Reyes S, Azevedo EC, Nagy SC, Alam IS, Sharma R, La Rosa SA, Moradi F, Cleland J, Shen B, James ML. Clinical Radiosynthesis and Translation of [F]OP-801: A Novel Radiotracer for Imaging Reactive Microglia and Macrophages. Acs Chemical Neuroscience. PMID 37310119 DOI: 10.1021/acschemneuro.3c00028 |
0.606 |
|
| 2023 |
Reyes ST, Azevedo EC, Cropper HC, Nagy S, Deal EM, Chaney AM, James ML. Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography. Journal of Visualized Experiments : Jove. PMID 36744792 DOI: 10.3791/64133 |
0.545 |
|
| 2022 |
van der Wildt B, Klockow JL, Miao Z, Reyes ST, Park JH, Shen B, Chin FT. Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain. Nuclear Medicine and Biology. 99-107. PMID 36371938 DOI: 10.1016/j.nucmedbio.2022.10.003 |
0.322 |
|
| 2022 |
Seo JW, Ajenjo J, Wu B, Robinson E, Raie MN, Wang J, Tumbale SK, Buccino P, Anders DA, Shen B, Habte FG, Beinat C, James ML, Reyes ST, Ravindra Kumar S, et al. Multimodal imaging of capsid and cargo reveals differential brain targeting and liver detargeting of systemically-administered AAVs. Biomaterials. 121701. PMID 35985893 DOI: 10.1016/j.biomaterials.2022.121701 |
0.541 |
|
| 2022 |
Jackson IM, Buccino PJ, Azevedo EC, Carlson ML, Luo ASZ, Deal EM, Kalita M, Reyes ST, Shao X, Beinat C, Nagy SC, Chaney AM, Anders DA, Scott PJH, Smith M, et al. Radiosynthesis and initial preclinical evaluation of [C]AZD1283 as a potential P2Y12R PET radiotracer. Nuclear Medicine and Biology. PMID 35680502 DOI: 10.1016/j.nucmedbio.2022.05.001 |
0.596 |
|
| 2021 |
Beinat C, Patel CB, Haywood T, Murty S, Naya L, Castillo JB, Reyes ST, Phillips M, Buccino P, Shen B, Park JH, Koran ME, Alam IS, James ML, Holley D, et al. A Clinical PET Imaging Tracer ([F]DASA-23) to Monitor Pyruvate Kinase M2 Induced Glycolytic Reprogramming in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34475101 DOI: 10.1158/1078-0432.CCR-21-0544 |
0.594 |
|
| 2021 |
van der Wildt B, Miao Z, Reyes ST, Park JH, Klockow JL, Zhao N, Romero A, Guo SG, Shen B, Windhorst AD, Chin FT. BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain. Nuclear Medicine and Biology. 100: 44-51. PMID 34174546 DOI: 10.1016/j.nucmedbio.2021.06.005 |
0.319 |
|
| 2021 |
van der Wildt B, Nezam M, Kooijman EJM, Reyes ST, Shen B, Windhorst AD, Chin FT. Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain. Bioorganic & Medicinal Chemistry. 42: 116245. PMID 34119698 DOI: 10.1016/j.bmc.2021.116245 |
0.302 |
|
| 2017 |
Shen B, Behera D, James ML, Reyes ST, Andrews L, Cipriano PW, Klukinov M, Lutz AB, Mavlyutov T, Rosenberg J, Ruoho AE, McCurdy CR, Gambhir SS, Yeomans DC, Biswal S, et al. Visualizing Nerve Injury in a Neuropathic Pain Model with [(18)F]FTC-146 PET/MRI. Theranostics. 7: 2794-2805. PMID 28824716 DOI: 10.7150/Thno.19378 |
0.517 |
|
| 2006 |
Reyes ST, Guo SG, Castillo JB, Wildt B, Morales AP, Park JH, Robowe N, Sprouse J, Missling CU, Chin FT. P4‐262: SIGMA‐1 RECEPTOR TARGET OCCUPANCY STUDY WITH DYNAMIC PET SCAN ANALYSIS OF ANAVEX
®
2‐73: A CLINICAL CANDIDATE FOR NEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES Alzheimer's & Dementia. 14. DOI: 10.1016/j.jalz.2018.07.084 |
0.333 |
|
| Show low-probability matches. |